{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:43:54Z","timestamp":1790725434695,"version":"4.1.0"},"reference-count":24,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicines"],"abstract":"<jats:p>Nausea and vomiting during pregnancy (NVP), particularly its severe form, Hyperemesis gravidarum (HG), affects up to 70% of pregnancies and significantly impacts the quality of life for those with the condition as well as generates a great economic burden, with annual costs exceeding $1.7 billion in the United States. Despite the available treatments targeting neurotransmitters like serotonin and dopamine, many patients experience inadequate relief and suffer from severe side effects, including headaches and dizziness. Recent research has underscored the role of GDF15, a protein mainly produced by the placenta and linked to NVP symptoms. This protein, part of the TGF-\u03b2 superfamily, has been implicated in appetite and weight regulation and is altered in those with HG due to specific genetic mutations. Addressing the challenges of delivering effective treatments, current innovations focus on targeting GDF15 to reduce symptoms while ensuring fetal safety. Promising therapeutic strategies include non-IgG immunotherapies, small peptide and molecule antagonists, and novel administration methods such as transdermal patches. These approaches aim to optimize dosage and reduce adverse effects. The effective development and testing of these treatments necessitate advanced animal models that closely resemble human pregnancy physiology, highlighting the need for further research and funding. This ongoing research holds significant potential to improve the clinical outcomes for HG patients and decrease the economic impact on healthcare systems, urging a dedicated response from the scientific and medical communities to advance these promising treatments.<\/jats:p>","DOI":"10.3390\/medicines11070017","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T03:45:21Z","timestamp":1725248721000},"page":"17","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["GDF15 Targeting for Treatment of Hyperemesis Gravidarum"],"prefix":"10.3390","volume":"11","author":[{"given":"Jamie","family":"Thygerson","sequence":"first","affiliation":[{"name":"Department of Chemistry and Physics, Southern Utah University, Cedar City, UT 84720, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dallin","family":"Oyler","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Physics, Southern Utah University, Cedar City, UT 84720, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Physics, Southern Utah University, Cedar City, UT 84720, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3031-8006","authenticated-orcid":false,"given":"Brandon","family":"Muse","sequence":"additional","affiliation":[{"name":"Department of Clinical Education, Rocky Vista University, Ivins, UT 84738, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-3074","authenticated-orcid":false,"given":"Benjamin D.","family":"Brooks","sequence":"additional","affiliation":[{"name":"Department of Clinical Education, Rocky Vista University, Ivins, UT 84738, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5348-3312","authenticated-orcid":false,"given":"Jessica E.","family":"Pullan","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Physics, Southern Utah University, Cedar City, UT 84720, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41586-023-06921-9","article-title":"GDF15 Linked to Maternal Risk of Nausea and Vomiting during Pregnancy","volume":"625","author":"Fejzo","year":"2024","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00737-016-0707-4","article-title":"Treatment Options for Hyperemesis Gravidarum","volume":"20","author":"Abramowitz","year":"2017","journal-title":"Arch. Women\u2019s Ment Health"},{"key":"ref_3","first-page":"e149","article-title":"Economic Burden of Nausea and Vomiting of Pregnancy in the USA","volume":"20","author":"Piwko","year":"2013","journal-title":"J. Popul. Ther. Clin. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000477853","article-title":"Hyperemesis Gravidarum: A Review of Recent Literature","volume":"100","author":"London","year":"2017","journal-title":"Pharmacology"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mares, R., Morrow, A., Shumway, H., Zapata, I., Forstein, D., and Brooks, B. (2022). Assessment of Management Approaches for Hyperemesis Gravidarum and Nausea and Vomiting of Pregnancy: A Retrospective Questionnaire Analysis. BMC Pregnancy Childbirth, 22.","DOI":"10.1186\/s12884-022-04922-6"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0959-8049(05)80255-2","article-title":"Ondansetron","volume":"29","author":"Roila","year":"1993","journal-title":"Eur. J. Cancer"},{"key":"ref_7","unstructured":"(2024, April 13). Promethazine Hydrochloride Tablets, USP, Available online: https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=4b21784b-3763-45b8-815a-c8380d17dc32&type=display."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Fejzo, M., Rocha, N., Cimino, I., Lockhart, S.M., Petry, C., Kay, R.G., Burling, K., Barker, P., George, A.L., and Yasara, N. (2023). Fetally-Encoded GDF15 and Maternal GDF15 Sensitivity Are Major Determinants of Nausea and Vomiting in Human Pregnancy. bioRxiv, bioRxiv:2023.06.02.542661.","DOI":"10.1101\/2023.06.02.542661"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of Early Drug Discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/1471-0528.17129","article-title":"Whole-exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum","volume":"129","author":"Fejzo","year":"2022","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/a-0830-1346","article-title":"Analysis of GDF15 and IGFBP7 in Hyperemesis Gravidarum Support Causality","volume":"79","author":"Fejzo","year":"2019","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41467-018-03258-0","article-title":"Placenta and Appetite Genes GDF15 and IGFBP7 Are Associated with Hyperemesis Gravidarum","volume":"9","author":"Fejzo","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/cen.14433","article-title":"Growth-Differentiation-Factor 15 Levels in Obese and Healthy Pregnancies: Relation to Insulin Resistance and Insulin Secretory Function","volume":"95","author":"Joelsson","year":"2021","journal-title":"Clin. Endocrinol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wischhusen, J., Melero, I., and Fridman, W.H. (2020). Growth\/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00951"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11237","DOI":"10.1021\/acs.jmedchem.3c00667","article-title":"Creation of a Peptide Antagonist of the GFRAL\u2013RET Receptor Complex for the Treatment of GDF15-Induced Malaise","volume":"66","author":"Borner","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"107902","DOI":"10.1016\/j.isci.2023.107902","article-title":"GDF15 Deficiency Hinders Human Trophoblast Invasion to Mediate Pregnancy Loss through Downregulating Smad1\/5 Phosphorylation","volume":"26","author":"Zeng","year":"2023","journal-title":"iScience"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm.4392","article-title":"GFRAL Is the Receptor for GDF15 and the Ligand Promotes Weight Loss in Mice and Nonhuman Primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","article-title":"Antibody-Mediated Inhibition of GDF15\u2013GFRAL Activity Reverses Cancer Cachexia in Mice","volume":"26","author":"Suriben","year":"2020","journal-title":"Nat. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","article-title":"Pathophysiological Role of Growth Differentiation Factor (GDF15) in Obesity, Cancer, and Cachexia","volume":"64","author":"Siddiqui","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"985646","DOI":"10.1155\/2012\/985646","article-title":"IgG Placental Transfer in Healthy and Pathological Pregnancies","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1530\/REP-20-0354","article-title":"Animal Models of Human Pregnancy and Placentation: Alternatives to the Mouse","volume":"160","author":"Carter","year":"2020","journal-title":"Reproduction"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"103676","DOI":"10.1016\/j.jri.2022.103676","article-title":"Understanding Main Pregnancy Complications through Animal Models","volume":"153","author":"Esparvarinha","year":"2022","journal-title":"J. Reprod. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/REP-12-0091","article-title":"Rabbit as a Reproductive Model for Human Health","volume":"144","author":"Fischer","year":"2012","journal-title":"Reproduction"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"E303","DOI":"10.1152\/ajpendo.00134.2023","article-title":"Cross-Species Comparison of Pregnancy-Induced GDF15","volume":"325","author":"Klein","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metab."}],"container-title":["Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2305-6320\/11\/7\/17\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:46:02Z","timestamp":1760111162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2305-6320\/11\/7\/17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["medicines11070017"],"URL":"https:\/\/doi.org\/10.3390\/medicines11070017","relation":{},"ISSN":["2305-6320"],"issn-type":[{"value":"2305-6320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]}}}